Recent studies revealed that NRP-1 could promote breast cancer cells resistance to ADM and PTX resistance through activation of ITGB3/FAK/NF-kB p65 axis and downregulation of BCRP/ABCG2 [9-11]. This evidence concerns the gene NRP1 and breast carcinoma.